Saturday, December 06, 2025 10:08:04 AM
I'll just address the IsoPet nonsense as the rest was too silly to respond to:
What's this horse manure about IsoPet being "early-stage medical tech"? Radiogel/IsoPet was invented over two decades ago. All the original patents are long expired. Isopet was launched a decade ago, a decade ago! And it's still sold below cost cuz there's no market for it to be sold above cost for a profit. All IsoPet expansion accomplishes is accelerate cash burn to bankruptcy. Moreover, we already know FDA doesn't consider IsoPet anecdotes in applications for Radiogel human trials. FDA needs controlled and monitored, statistically valid animal data. One off anecdotes of random animals is of no help getting Radiogel to market.
That's what makes IsoPet a hopeless distraction
Yes, by all appearances, RDGL is a stock selling scam to fund MK's lifestyle, including his pet project called IsoPet. Hardly a stable business model anybody with sense should invest in. RDGL isn't even a good trade, as the average volume is far too low for that
What's this horse manure about IsoPet being "early-stage medical tech"? Radiogel/IsoPet was invented over two decades ago. All the original patents are long expired. Isopet was launched a decade ago, a decade ago! And it's still sold below cost cuz there's no market for it to be sold above cost for a profit. All IsoPet expansion accomplishes is accelerate cash burn to bankruptcy. Moreover, we already know FDA doesn't consider IsoPet anecdotes in applications for Radiogel human trials. FDA needs controlled and monitored, statistically valid animal data. One off anecdotes of random animals is of no help getting Radiogel to market.
That's what makes IsoPet a hopeless distraction
Yes, by all appearances, RDGL is a stock selling scam to fund MK's lifestyle, including his pet project called IsoPet. Hardly a stable business model anybody with sense should invest in. RDGL isn't even a good trade, as the average volume is far too low for that
Recent RDGL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:45:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
